Researchers at the Weizmann Institute have identified why roughly half of prostate cancers become resistant to standard hormone therapy.
← News
Medicine Breakthroughs Medicine Breakthroughs Health
Novel molecular marker may improve prostate cancer treatment
~50% prostate cancers Gene fusion affects
Dual Androgen+Cortisol Therapy Treatment approach
May Worsen Outcomes In Fusion Cases Steroid drugs